Omeros (OMER) Long-Term Debt Issuances (2010 - 2020)
Omeros (OMER) posted Long-Term Debt Issuances of $225.0 million for Q3 2020, up 157.06% sequentially from $87.5 million in Q4 2018.
Analysis
Omeros (OMER) Long-Term Debt Issuances (2010 - 2020) Analysis & Trends
Omeros has reported Long-Term Debt Issuances for 9 years, with the latest figure at $225.0 million in Q3 2020.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $225.0 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $312.5 million (changed N/A YoY) and the FY2020 annual result came in at $225.0 million, changed N/A from the prior year.
- Long-Term Debt Issuances rose to $225.0 million in Q3 2020 per OMER's latest filing, from $87.5 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $225.0 million in Q3 2020 and troughed at -$19.8 million in Q3 2016.
- A 4-year average of $58.9 million and a median of $19.9 million in 2016 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2016 and 2017: Long-Term Debt Issuances surged 99.88% in 2016, then plunged 100.26% in 2017.
- Over 4 years, Long-Term Debt Issuances stood at $99.9 million in 2016, then slumped by 100.05% to -$51000.0 in 2017, then surged by 171721.57% to $87.5 million in 2018, then surged by 157.06% to $225.0 million in 2020.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $225.0 million, $87.5 million, and -$51000.0 for Q3 2020, Q4 2018, and Q2 2017 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Omeros | 1.38 Bn | 1.38 Bn | 27.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 225.00 Mn |
| Dec 31, 2018 | 165.45 Mn |
| Jun 30, 2017 | -51,000.00 |
| Mar 31, 2017 | 51,000.00 |
| Dec 31, 2016 | 80.14 Mn |
| Jun 30, 2016 | 19.86 Mn |
| Dec 31, 2015 | 248,000.00 |
| Sep 30, 2015 | 2.40 Mn |
| Jun 30, 2015 | 2.34 Mn |
| Dec 31, 2014 | 19.30 Mn |
| Mar 31, 2014 | 12.70 Mn |
| Dec 31, 2012 | 1.90 Mn |
| Sep 30, 2012 | 1.57 Mn |
| Jun 30, 2012 | 1.53 Mn |
| Mar 31, 2012 | 1.50 Mn |
| Mar 31, 2011 | 9.94 Mn |
| Dec 31, 2010 | 8.88 Mn |
| Sep 30, 2010 | 1.42 Mn |